Live Cell Imaging Market - Industry Size, Share, Growth & Forecast 2027 | UnivDatos

 

Cancer is the second leading cause of death worldwide and is responsible for an estimated 9.6 million deaths in 2018. Globally, about 1 in 6 deaths is due to cancer. Approximately 70% of deaths from cancer occur in low- and middle-income countries. Nearly one-third of deaths from cancer are due to the 5 leading behavioral and dietary risks: high body mass index, low fruit, and vegetable intake, lack of physical activity, tobacco use, and alcohol use. GLOBOCAN 2020 with new estimates on the global cancer burden, indicating that it has risen to 19.3 million cases and 10 million cancer deaths in 2020. Worldwide, an estimated 28.4 million new cancer cases (including NMSC, except basal cell carcinoma) are projected to occur in 2040, a 47% increase from the corresponding 19.3 million cases in 2020, assuming that national rates estimated in 2020 remain constant. This rising prevalence of cancer globally is increasing the demand for live-cell imaging systems to visualize and localize the cancer cells in real-time.

Download Free Sample of this Report - https://univdatos.com/get-a-free-sample-form-php/?product_id=19869

According to UnivDatos Market Insights (UMI)’ research report “Global Live Cell Imaging Market Analysis, 2020”, the live cell imaging market is projected to grow at a CAGR of 8% during 2021-27F. the growing research & development activities in various biotechnology and pharmaceutical companies, growing adoption of high-content screening techniques in drug discovery, and rising government funding for cell-based research are some of the other prominent factors contributing to the growth of the market globally.

Based on the application, the market is fragmented into cell biology, developmental biology, stem cell & drug discovery, and others. The cell biology segment accounted for a considerable share in 2020 and is anticipated to register a lucrative CAGR during the forecast period because of a substantial increase in the research and development studies performed on molecular interaction networks as live-cell imaging technology is used for understanding the elemental cellular structures as well as their interaction on the tissue level.

Pharmaceutical & Biotechnology Companies Segment to Witness Robust growth

Based on end-users, the market is segmented into pharmaceutical & biotechnology companies, academic & research institutes, and contract research organizations(CROs). The pharmaceutical & biotechnology companies segment had the highest revenue and CAGR growth in the analyzed period. The growth of this segment is attributed to the growing focus on cell-based research & development activities for among these companies and increasing number of patents of various drugs.

Download Free Sample of this Report - https://univdatos.com/get-a-free-sample-form-php/?product_id=19869

North America to Grab Lion’s Share, and witnessed Explicit Growth

Based on the region, North America dominated the global live cell imaging market in 2020. The region is projected to maintain its dominance during the forecasted period 2021-27 owing to the growing healthcare expenditure and increased elderly population in the region. North America is expected to skyrocket with a CAGR of XX% in the forecast period owing, as stated in UnivDatos Market Insights (UMI)’ research report “Global Live Cell Imaging Market Analysis, 2020”. 

According to UnivDatos Market Insights (UMI)’, the key players with a considerable market share in the Live Cell Imaging Market include PerkinElmer, Inc., Becton, Dickinson and Company, Carl Zeiss AG, Danaher Corporation, Olympus Corporation, Sartorius AG, Thermo Fisher Scientific, Nikon Corporation, Biotek Instruments, Inc., CytoSMART Technologies, among others. The players are focused on launching products for gaining customers' traction and expanding their geographical reach to get a competitive edge in the industry.  

“Global Live Cell Imaging Market Analysis, 2020” provides comprehensive qualitative and quantitative insights on the industry potential, key factors impacting sales and purchase decisions, hotspots, and opportunities available for live cell imging providers across the Globe. Moreover, the report also encompasses the key strategic imperatives for success for competitors along with strategic factorial indexing measuring competitor's capabilities on 16 parameters. This will help companies in the formulation of go to Market Strategies and identifying the blue ocean for its offerings.

For More Informative Information, Please Visit Us – https://univdatos.com/report/live-cell-imaging-market/

Market Segmentation:

1.      By Product (Equipment, Consumables, and Software)

2.      By Technology (Time-Lapse Microscopy, Fluorescence Recovery After Photobleaching, Fluorescence Resonance Energy Transfer, High Content Screening, and Others)

3.      By Application (Cell Biology, Developmental Biology, Stem Cell & Drug Discovery, and Others)

4.      By End-Users (Pharmaceutical & Biotechnology Companies, Academic & Research Institutes, and Contract Research Organizations(CROs))

5.      By Region (North America, Europe, Asia-Pacific, Rest of the World)

6.      By Company (PerkinElmer, Inc., Becton, Dickinson and Company, Carl Zeiss AG, Danaher Corporation, Olympus Corporation, Sartorius AG, Thermo Fisher Scientific, Nikon Corporation, Biotek Instruments, Inc., CytoSMART Technologies, etc.)

Key questions answered in the study:

1.      What are the current and future trends of the live cell imaging industry?

2.      How the industry has been evolving in terms of product, application, technology, and distribution channels?

3.      How the competition has been shaping across the countries followed by their comparative factorial indexing?

4.      What are the key growth drivers and challenges for the live cell imaging industry?

5.      What is the customer orientation, purchase behavior, and expectations from live cell imaging firms across various regions?

Table of Content –

1 MARKET INTRODUCTION

2 RESEARCH METHODOLOGY OR ASSUMPTION

3 MARKET SYNOPSIS

4 EXECUTIVE SUMMARY

5 COVID-19 IMPACT

6 GLOBAL LIVE CELL IMAGING MARKET REVENUE

7 MARKET INSIGHTS BY PRODUCT

8 MARKET INSIGHTS BY TECHNOLOGY

9 MARKET INSIGHTS BY APPLICATION

10 MARKET INSIGHTS BY END-USERS

11 MARKET INSIGHTS BY REGION

12 LIVE CELL IMAGING MARKET DYNAMICS

13 LIVE CELL IMAGING MARKET OPPORTUNITIES

14 LIVE CELL IMAGING MARKET TRENDS & INSIGHTS

15 LEGAL & REGULATORY FRAMEWORK

16 DEMAND AND SUPPLY SIDE ANALYSIS

17 VALUE CHAIN ANALYSIS

18 COMPETITIVE SCENARIO

19 COMPANY PROFILED

20 DISCLAIMER

Browse Other Related Research Reports from UnivDatos Market Insights

·        Oncology Therapeutics Market to exceed US$ 247.5 Billion by 2027 Globally |CAGR: 8.2%|

·        Neuromodulation Devices Market to exceed US$ 11.7 Billion by 2027 Globally |CAGR: 8.4%| 

·        Digital Health Market to exceed US$ 746 Billion by 2027 Globally | CAGR: 26.3% |

·        Heart Pump Devices Market to exceed US$ 6 Billion by 2027 Globally | CAGR: 18.9% |